Last week, the Senate confirmed Robert Califf to run the FDA by a narrow vote of 50-46. Califf had previously served as the FDA Commissioner in the final months of Obama’s presidency before Janet Woodcock took over as interim chief. After a 13-month holding pattern, placing Califf as a permanent leader will hopefully bring some stability to the agency. A recent POLITICO article (well worth reading the full article) discussed 6 challenges that await Califf as he takes the reins. The include:
6 Challenges Facing the New FDA Commissioner
Robert Califf returns to a permanent position, but the political landscape has changed a lot since he last acted as Commissioner.
Feb 18, 2022
Recommended
Recommended
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
